FSA
CVS icon

Fort Sheridan Advisors’s CVS Health CVS Stock Holding History

Fort Sheridan Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Hold
6,507
– – 0.06% 193
2025
Q4 		$516K Hold
6,507
– – 0.07% 165
2025
Q3 		$491K Buy
6,507
+3,588
+123% +$246K 0.06% 167
2025
Q2 		$201K Sell
2,919
-400
-12% -$26.2K 0.03% 244
2025
Q1 		$225K Sell
3,319
-5,130
-61% -$307K 0.03% 230
2024
Q4 		$379K Sell
8,449
-200
-2% -$11.2K 0.06% 188
2024
Q3 		$544K Sell
8,649
-1,215
-12% -$70.9K 0.08% 146
2024
Q2 		$583K Sell
9,864
-6,769
-41% -$423K 0.09% 131
2024
Q1 		$1.33M Sell
16,633
-3,790
-19% -$290K 0.25% 73
2023
Q4 		$1.61M Buy
20,423
+506
+3% +$36K 0.32% 60
2023
Q3 		$1.39M Buy
19,917
+2,570
+15% +$182K 0.32% 58
2023
Q2 		$1.2M Buy
17,347
+3,559
+26% +$253K 0.27% 67
2023
Q1 		$1.02M Buy
13,788
+2,750
+25% +$231K 0.26% 70
2022
Q4 		$1.03M Sell
11,038
-276
-2% -$26.6K 0.33% 55
2022
Q3 		$1.08M Buy
11,314
+358
+3% +$35.4K 0.36% 53
2022
Q2 		$1.01M Buy
10,956
+120
+1% +$11.7K 0.33% 54
2022
Q1 		$1.1M Sell
10,836
-626
-5% -$65.8K 0.32% 56
2021
Q4 		$1.18M Buy
11,462
+836
+8% +$77.3K 0.34% 54
2021
Q3 		$902K Buy
10,626
+38
+0.4% +$3.18K 0.3% 61
2021
Q2 		$883K Buy
10,588
+3,693
+54% +$302K 0.29% 60
2021
Q1 		$519K Buy
6,895
+75
+1% +$5.46K 0.21% 77
2020
Q4 		$466K Buy
6,820
+400
+6% +$26K 0.23% 62
2020
Q3 		$375K Sell
6,420
-69
-1% -$4.29K 0.22% 63
2020
Q2 		$422K Buy
6,489
+1,612
+33% +$102K 0.26% 55
2020
Q1 		$289K Buy
4,877
+265
+6% +$17.7K 0.21% 59
2019
Q4 		$343K Buy
4,612
+4
+0.1% +$281 0.18% 73
2019
Q3 		$291K Buy
+4,608
New +$273K 0.16% 71

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort Sheridan Advisors's CVS Position: Q1 2026 in Review

Fort Sheridan Advisors held its CVS Health (CVS) position steady in Q1 2026 at 6,507 shares worth $467K. The position accounts for 0.06% of the portfolio, ranked #193.

Fort Sheridan Advisors first reported a position in CVS in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.61M in Q4 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Fort Sheridan Advisors held 6,507 shares of CVS Health worth $467K as of Q1 2026.
  • Fort Sheridan Advisors left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.06% of Fort Sheridan Advisors's portfolio in Q1 2026, its #193 holding.
  • Fort Sheridan Advisors first reported a position in CVS Health in Q3 2019 and has held it in 27 quarters since.
  • Fort Sheridan Advisors's CVS Health position peaked at $1.61M in Q4 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.